Table of Contents Author Guidelines Submit a Manuscript
Journal of Cancer Epidemiology
Volume 2012, Article ID 792034, 10 pages
http://dx.doi.org/10.1155/2012/792034
Research Article

Serum Lipids and the Risk of Gastrointestinal Malignancies in the Swedish AMORIS Study

1Cancer Epidemiology Group, Division of Cancer Studies, School of Medicine, King’s College London, London, UK
2Regional Cancer Centre, Uppsala University Hospital, Uppsala, Sweden
3Department of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
4AstraZeneca R&D, Södertalje, Sweden
5Clinical Epidemiological Unit, Department of Medicine, Karolinska Institutet and CALAB Research, Stockholm, Sweden
6Department of Medicine and Department of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden

Received 27 April 2012; Accepted 17 July 2012

Academic Editor: Lynnette Ferguson

Copyright © 2012 Wahyu Wulaningsih et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. C. Goff, A. G. Bertoni, H. Kramer et al., “Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA): gender, ethnicity, and coronary artery calcium,” Circulation, vol. 113, no. 5, pp. 647–656, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Ghandehari, S. Kamal-Bahl, and N. D. Wong, “Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: the National Health and Nutrition Examination Survey 2003-2004,” American Heart Journal, vol. 156, no. 1, pp. 112–119, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. D. F. Wyszynski, D. M. Waterworth, P. J. Barter et al., “Relation between atherogenic dyslipidemia and the Adult Treatment Program-III definition of metabolic syndrome (Genetic Epidemiology of Metabolic Syndrome Project),” American Journal of Cardiology, vol. 95, no. 2, pp. 194–198, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. R. L. Ahmed, K. H. Schmitz, K. E. Anderson, W. D. Rosamond, and A. R. Folsom, “The metabolic syndrome and risk of incident colorectal cancer,” Cancer, vol. 107, no. 1, pp. 28–36, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Bjørge, A. Lukanova, H. Jonsson et al., “Metabolic syndrome and breast cancer in the Me-Can (metabolic syndrome and cancer) project,” Cancer Epidemiology Biomarkers and Prevention, vol. 19, no. 7, pp. 1737–1745, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Russo, M. Autelitano, and L. Bisanti, “Metabolic syndrome and cancer risk,” European Journal of Cancer, vol. 44, no. 2, pp. 293–297, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Tabuchi, J. Kitayama, and H. Nagawa, “Hypertriglyceridemia is positively correlated with the development of colorectal tubular adenoma in Japanese men,” World Journal of Gastroenterology, vol. 12, no. 8, pp. 1261–1264, 2006. View at Google Scholar · View at Scopus
  8. H. Ulmer, W. Borena, K. Rapp et al., “Serum triglyceride concentrations and cancer risk in a large cohort study in Austria,” British Journal of Cancer, vol. 101, no. 7, pp. 1202–1206, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. F. J. B. Van Duijnhoven, H. B. Bueno-De-Mesquita, M. Calligaro et al., “Blood lipid and lipoprotein concentrations and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition,” Gut, vol. 60, no. 8, pp. 1094–1102, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Iso, A. Ikeda, M. Inoue, S. Sato, and S. Tsugane, “Serum cholesterol levels in relation to the incidence of cancer: the JPHC study cohorts,” International Journal of Cancer, vol. 125, no. 11, pp. 2679–2686, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. P. H. Chyou, A. M. Y. Nomura, G. N. Stemmermann, and I. Kato, “Prospective study of serum cholesterol and site-specific cancers,” Journal of Clinical Epidemiology, vol. 45, no. 3, pp. 287–292, 1992. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Konradsen, H. Ag, F. Lindberg, S. Hexeberg, and R. Jorde, “Serum 1,25-dihydroxy vitamin D is inversely associated with body mass index,” European Journal of Nutrition, vol. 47, no. 2, pp. 87–91, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. A. G. Renehan, M. Tyson, M. Egger, R. F. Heller, and M. Zwahlen, “Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies,” The Lancet, vol. 371, no. 9612, pp. 569–578, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Ahotupa, J. P. Suomela, T. Vuorimaa, and T. Vasankari, “Lipoprotein-specific transport of circulating lipid peroxides,” Annals of Medicine, vol. 42, no. 7, pp. 521–529, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. I. Erdelyi, N. Levenkova, E. Y. Lin et al., “Western-style diets induce oxidative stress and dysregulate immune responses in the colon in a mouse model of sporadic colon cancer,” Journal of Nutrition, vol. 139, no. 11, pp. 2072–2078, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Moustafa, P. Fickert, C. Magnes et al., “Alterations in lipid metabolism mediate inflammation, fibrosis, and proliferation in a mouse model of chronic cholestatic liver injury,” Gastroenterology, vol. 142, no. 1, pp. 140–151.e12, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Hsieh, A. A. Hayashi, J. Webb, and K. Adeli, “Postprandial dyslipidemia in insulin resistance: mechanisms and role of intestinal insulin sensitivity,” Atherosclerosis Supplements, vol. 9, no. 2, pp. 7–13, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Ji, Y. Sakata, and P. Tso, “Nutrient-induced inflammation in the intestine,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 14, no. 4, pp. 315–321, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. S. T. Mayne and S. A. Navarro, “Diet, obesity and reflux in the etiology of adenocarcinomas of the esophagus and gastric cardia in humans,” Journal of Nutrition, vol. 132, no. 11, supplement, pp. 3467S–3470S, 2002. View at Google Scholar · View at Scopus
  20. R. Järvinen, P. Knekt, T. Hakulinen, H. Rissanen, and M. Heliövaara, “Dietary fat, cholesterol and colorectal cancer in a prospective study,” British Journal of Cancer, vol. 85, no. 3, pp. 357–361, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Lucenteforte, C. Bosetti, S. Gallus et al., “Macronutrients, fatty acids and cholesterol intake and stomach cancer risk,” Annals of Oncology, vol. 20, no. 8, pp. 1434–1438, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. I. Jungner, S. M. Marcovina, G. Walldius, I. Holme, W. Kolar, and E. Steiner, “Apolipoprotein B and A-I values in 147 576 Swedish males and females, standardized according to the World Health Organization-International Federation of Clinical Chemistry First International Reference Materials,” Clinical Chemistry, vol. 44, no. 8 I, pp. 1641–1649, 1998. View at Google Scholar · View at Scopus
  23. G. Walldius, I. Jungner, I. Holme, A. H. Aastveit, W. Kolar, and E. Steiner, “High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study,” The Lancet, vol. 358, no. 9298, pp. 2026–2033, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. I. Holme, A. H. Aastveit, I. Jungner, and G. Walldius, “Relationships between lipoprotein components and risk of myocardial infarction: age, gender and short versus longer follow-up periods in the Apolipoprotein MOrtality RISk study (AMORIS),” Journal of Internal Medicine, vol. 264, no. 1, pp. 30–38, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. I. Holme, A. H. Aastveit, N. Hammar, I. Jungner, and G. Walldius, “Relationships between lipoprotein components and risk of ischaemic and haemorrhagic stroke in the Apolipoprotein MOrtality RISk study (AMORIS),” Journal of Internal Medicine, vol. 265, no. 2, pp. 275–287, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. G. Walldius, I. Jungner, W. Kolar, I. Holme, and E. Steiner, “High cholesterol and triglyceride values in Swedish males and females: increased risk of fatal myocardial infarction. First report from the AMORIS (Apolipoprotein related MOrtality RISk) study,” Blood Pressure, vol. 4, supplement, pp. 35–42, 1992. View at Google Scholar · View at Scopus
  27. M. Van Hemelrijck, H. Garmo, E. Binda et al., “Immunoglobulin e and cancer: a meta-analysis and a large Swedish cohort study,” Cancer Causes and Control, vol. 21, no. 10, pp. 1657–1667, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Van Hemelrijck, H. Garmo, L. Holmberg et al., “Prostate cancer risk in the Swedish AMORIS study: the interplay between triglycerides, total cholesterol, and glucose,” Cancer, vol. 117, pp. 2086–2095, 2011. View at Google Scholar
  29. Central Bureau for Statistics, Statistics Sweden, Central Bureau for Statistics, Stockholm, Sweden, 2008.
  30. C. A. Swanson, N. Potischman, R. J. Barrett et al., “Endometrial cancer risk in relation to serum lipids and lipoprotein levels,” Cancer Epidemiology Biomarkers and Prevention, vol. 3, no. 7, pp. 575–581, 1994. View at Google Scholar · View at Scopus
  31. G. Walldius and I. Jungner, “The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy—a review of the evidence,” Journal of Internal Medicine, vol. 259, no. 5, pp. 493–519, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. I. Jungner, G. Walldius, I. Holme, W. Kolar, and E. Steiner, “Apolipoprotein B and A-I in relation to serum cholesterol and triglycerides in 43 000 Swedish males and females,” International Journal of Clinical & Laboratory Research, vol. 21, no. 2-4, pp. 247–255, 1992. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Millán, X. Pintó, A. Muñoz et al., “Lipoprotein ratios: physiological significance and clinical usefulness in cardiovascular prevention,” Vascular Health and Risk Management, vol. 5, pp. 757–765, 2009. View at Google Scholar · View at Scopus
  34. J. I. Cleeman, “Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III),” Journal of the American Medical Association, vol. 285, no. 19, pp. 2486–2497, 2001. View at Google Scholar · View at Scopus
  35. A. Negre-Salvayre, C. Coatrieux, C. Ingueneau, and R. Salvayre, “Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors,” British Journal of Pharmacology, vol. 153, no. 1, pp. 6–20, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. K. Mizia-Stec, B. Zahorska-Markiewicz, T. Mandecki et al., “Hyperlipidaemias and serum cytokines in patients with coronary artery disease,” Acta Cardiologica, vol. 58, no. 1, pp. 9–15, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. G. Zuliani, S. Volpato, A. Blè et al., “High interleukin-6 plasma levels are associated with low HDL-C levels in community-dwelling older adults: the InChianti study,” Atherosclerosis, vol. 192, no. 2, pp. 384–390, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. K. Cianflone, S. Paglialunga, and C. Roy, “Intestinally derived lipids: metabolic regulation and consequences-An overview,” Atherosclerosis Supplements, vol. 9, no. 2, pp. 63–68, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. R. Novosyadlyy, D. E. Lann, A. Vijayakumar et al., “Insulin-mediated acceleration of breast cancer development and progression in a nonobese model of type 2 diabetes,” Cancer Research, vol. 70, no. 2, pp. 741–751, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. M.-H. Cheng, H.-F. Chiu, S.-C. Ho, S.-S. Tsai, T.-N. Wu, and C.-Y. Yang, “Statin use and the risk of colorectal cancer: a population-based case-control study,” World Journal of Gastroenterology, vol. 17, no. 47, pp. 5197–5202, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. H.-F. Chiu, S.-C. Ho, C.-C. Chang, T.-N. Wu, and C.-Y. Yang, “Statins are associated with a reduced risk of gastric cancer: a population-based case-control study,” American Journal of Gastroenterology, vol. 106, no. 12, pp. 2098–2103, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. M. S. Simon, C. A. Rosenberg, R. J. Rodabough et al., “Prospective analysis of association between use of statins or other lipid-lowering agents and colorectal cancer risk,” Annals of Epidemiology, vol. 22, no. 1, pp. 17–27, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. M. G. O'Doherty, N. D. Freedman, A. R. Hollenbeck, A. Schatzkin, and C. C. Abnet, “A prospective cohort study of obesity and risk of oesophageal and gastric adenocarcinoma in the NIH-AARP Diet and Health Study,” Gut, vol. 61, no. 9, pp. 1261–1268, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. M. G. O'Doherty, M. M. Cantwell, L. J. Murray, L. A. Anderson, and C. C. Abnet, “Dietary fat and meat intakes and risk of reflux esophagitis, Barrett's esophagus and esophageal adenocarcinoma,” International Journal of Cancer, vol. 129, no. 6, pp. 1493–1502, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. Z. F. Zhang, R. C. Kurtz, G. P. Yu et al., “Adenocarcinomas of the esophagus and gastric cardia: the role of diet,” Nutrition and Cancer, vol. 27, no. 3, pp. 298–309, 1997. View at Google Scholar · View at Scopus
  46. A. Sako, J. Kitayama, S. Kaisaki, and H. Nagawa, “Hyperlipidemia is a risk factor for lymphatic metastasis in superficial esophageal carcinoma,” Cancer Letters, vol. 208, no. 1, pp. 43–49, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. K. Nishi, H. Itabe, M. Uno et al., “Oxidized LDL in carotid plaques and plasma associates with plaque instability,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 22, no. 10, pp. 1649–1654, 2002. View at Publisher · View at Google Scholar · View at Scopus
  48. Y. Wang, H. Li, Y. Diao et al., “Relationship between oxidized LDL antibodies and different stages of esophageal carcinoma,” Archives of Medical Research, vol. 39, no. 8, pp. 760–767, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. J. Lagergren and P. Lagergren, “Oesophageal cancer,” British Medical Journal, vol. 341, p. c6280, 2010. View at Google Scholar · View at Scopus
  50. J. J. Rivera, K. Nasir, C. Campbell, J. A. M. Carvalho, R. S. Blumenthal, and R. D. Santos, “Relation of plasma lipoprotein levels with low-grade inflammation in white men without clinical evidence of myocardial ischemia,” American Journal of Cardiology, vol. 100, no. 3, pp. 450–454, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. M. K. Jung, S. W. Jeon, C. M. Cho et al., “Hyperglycaemia, hypercholesterolaemia and the risk for developing gastric dysplasia,” Digestive and Liver Disease, vol. 40, no. 5, pp. 361–365, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. W. Borena, T. Stocks, H. Jonsson et al., “Serum triglycerides and cancer risk in the metabolic syndrome and cancer (Me-Can) collaborative study,” Cancer Causes and Control, vol. 22, no. 2, pp. 291–299, 2011. View at Publisher · View at Google Scholar · View at Scopus
  53. C. M. Kitahara, A. B. De González, N. D. Freedman et al., “Total cholesterol and cancer risk in a large prospective study in Korea,” Journal of Clinical Oncology, vol. 29, no. 12, pp. 1592–1598, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. J. Bornschein, T. Rokkas, M. Selgrad, and P. Malfertheiner, “Helicobacter pylori and clinical aspects of gastric cancer,” Helicobacter, vol. 14, no. 1, pp. 41–45, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. J. P. F. Angeli, C. C. M. Garcia, F. Sena et al., “Lipid hydroperoxide-induced and hemoglobin-enhanced oxidative damage to colon cancer cells,” Free Radical Biology and Medicine, vol. 51, no. 2, pp. 503–515, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. T.-H. Tseng, J.-D. Hsu, C.-Y. Chu, and C.-J. Wang, “Promotion of colon carcinogenesis through increasing lipid peroxidation induced in rats by a high cholesterol diet,” Cancer Letters, vol. 100, no. 1-2, pp. 81–87, 1996. View at Publisher · View at Google Scholar · View at Scopus
  57. L. A. Davidson, J. L. Lupton, Y. H. Jiang, and R. S. Chapkin, “Carcinogen and dietary lipid regulate ras expression and localization in rat colon without affecting farnesylation kinetics,” Carcinogenesis, vol. 20, no. 5, pp. 785–791, 1999. View at Google Scholar · View at Scopus
  58. M. K. Kim, S. Sasaki, T. Otani, and S. Tsugane, “Dietary patterns and subsequent colorectal cancer risk by subsite: a prospective cohort study,” International Journal of Cancer, vol. 115, no. 5, pp. 790–798, 2005. View at Publisher · View at Google Scholar · View at Scopus
  59. M. Van Hemelrijck, Metabolic syndrome and prostate cancer: biomarkers and treatment side-effects [Ph.D. thesis], King's College London, London, UK, 2010.
  60. N. Magrini, T. Einarson, A. Vaccheri, P. McManus, N. Montanaro, and U. Bergman, “Use of lipid-lowering drugs from 1990 to 1994: an international comparison among Australia, Finland, Italy (Emilia Romagna Region), Norway and Sweden,” European Journal of Clinical Pharmacology, vol. 53, no. 3-4, pp. 185–189, 1997. View at Publisher · View at Google Scholar · View at Scopus
  61. A. D. Patterson, O. Maurhofer, D. Beyoǧlu et al., “Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profiling,” Cancer Research, vol. 71, no. 21, pp. 6590–6600, 2011. View at Publisher · View at Google Scholar · View at Scopus